Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    feinberg school of medicine OR northwestern university medical school | ALS
Show Display Options
Rank Status Study
1 Recruiting Genetics of Familial and Sporadic ALS
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
2 Completed
Has Results
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
Condition: SYSTEMIC SCLERODERMA
Interventions: Drug: standard of care;   Procedure: stem cell transplantation
3 Completed
Has Results
Clinical Trial Ceftriaxone in Subjects With ALS
Conditions: Amyotrophic Lateral Sclerosis;   ALS
Interventions: Drug: ceftriaxone;   Other: placebo
4 Active, not recruiting Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: tirasemtiv;   Drug: Placebo tablets
5 Completed
Has Results
Clinical Trial of High Dose CoQ10 in ALS
Conditions: Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease
Interventions: Drug: coenzyme Q10;   Drug: Placebo
6 Withdrawn A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo;   Drug: Arimoclomol
7 Terminated Phase 3 Extension Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Dexpramipexole
8 Completed Phase 3 Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Dexpramipexole;   Drug: Placebo
9 Completed
Has Results
Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
Condition: Pseudobulbar Affect (PBA)
Interventions: Drug: dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg;   Drug: dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg;   Drug: Placebo
10 Completed Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: AVP-923
11 Completed S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclosporine

Study has passed its completion date and status has not been verified in more than two years.